These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3402526)

  • 21. Total and free plasma and total synovial fluid piroxicam concentrations: relationship to antiinflammatory effect in patients with reactive arthritis and other arthritides.
    Hundal O; Kvien TK; Glennås A; Andrup O; Karstensen B; Thoen JE; Rugstad HE
    Scand J Rheumatol; 1993; 22(4):183-7. PubMed ID: 8356411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relation between clinical response and plasma and synovial fluid levels of piroxicam].
    Chérié Lignière G
    Clin Ter; 1984 Feb; 108(4):297-304. PubMed ID: 6232066
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum concentration of piroxicam and inhibition of platelet aggregation in patients with rheumatoid arthritis and M. Bechterew.
    Koytchev R; Alken RG; Gromnica-Ihle E
    Agents Actions; 1994 Nov; 43(1-2):48-52. PubMed ID: 7741041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
    Bird HA; Allen JG; Dixon JS; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):47-52. PubMed ID: 3879830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid.
    Bertin P; Lapicque F; Payan E; Rigaud M; Bailleul F; Jaeger S; Treves R; Netter P
    Eur J Clin Pharmacol; 1994; 46(1):3-7. PubMed ID: 8005184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piroxicam in breast milk after long-term treatment.
    Ostensen M; Matheson I; Laufen H
    Eur J Clin Pharmacol; 1988; 35(5):567-9. PubMed ID: 3234465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Trans-synovial kinetics of tiaprofenic acid].
    Kurowski M
    Z Rheumatol; 1988; 47(3):173-6. PubMed ID: 3213265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolmetin kinetics and synovial fluid prostaglandin E levels in rheumatoid arthritis.
    Dromgoole SH; Furst DE; Desiraju RK; Nayak RK; Kirschenbaum MA; Paulus HE
    Clin Pharmacol Ther; 1982 Sep; 32(3):371-7. PubMed ID: 7105628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [6-methoxy-2-naphthylacetic acid level in plasma, synovial fluid and adjacent tissue in patients with rheumatoid arthritis or gonarthroses after a 4-day therapy with nabumetone (Arthaxan)].
    Miehlke RK; Schneider S; Sörgel F; Muth P; Henschke F; Fedder M
    Z Rheumatol; 1991; 50(2):103-8. PubMed ID: 1872041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of diflunisal and piroxicam in the management of patients with rheumatoid arthritis.
    Rice DM
    Clin Ther; 1987; 10(1):92-7. PubMed ID: 3329968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.
    Aarons L; Salisbury R; Alam-Siddiqi M; Taylor L; Grennan DM
    Br J Clin Pharmacol; 1986 Feb; 21(2):155-63. PubMed ID: 3954931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osmosin: its effect on plasma and synovial fluid kinetics of indomethacin.
    Fowler PD; Dawes PT
    Eur J Clin Pharmacol; 1985; 27(6):689-91. PubMed ID: 3987775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single and multiple oral dose pharmacokinetics of tenoxicam in the elderly.
    Bird HA; Francis RJ; Le Gallez P; Hill J; Dixon JS; Allen JG; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):60-9. PubMed ID: 3879831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quantitative and qualitative changes in the fibronectin level in rheumatoid arthritis].
    Abdullin AR; Litvinov RI; Zinkevich OD; Salikov IG
    Ter Arkh; 1988; 60(4):89-94. PubMed ID: 3394105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis.
    Fowler PD; Shadforth MF; Crook PR; John VA
    Eur J Clin Pharmacol; 1983; 25(3):389-94. PubMed ID: 6628528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma and synovial fluid meclofenamic acid concentrations in patients with rheumatoid arthritis of the knee.
    Koup JR; Thomas D; Tucker E; Black A; Ruderman M; Dixon JA; Kinkel A
    Eur J Clin Pharmacol; 1988; 35(2):199-202. PubMed ID: 3191939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenoxicam and ketoprofen level monitoring with high performance liquid chromatography in patients affected by rheumatoid arthritis.
    Corvetta A; Della Bitta R; Luchetti MM; Pomponio G; Ciuffoletti V
    Clin Exp Rheumatol; 1991; 9(2):143-8. PubMed ID: 2060161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum and synovial fluid concentrations of endothelin-1 in patients with rheumatoid arthritis.
    Haq A; El-Ramahi K; Al-Dalaan A; Al-Sedairy ST
    J Med; 1999; 30(1-2):51-60. PubMed ID: 10515240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma and synovial fluid lanthanides in rheumatoid arthritis: variations after intra-articular therapy.
    Cutolo M; Oddone M; Accardo S; Balleari E; Collecchi P; Mora E; Esposito M
    Clin Exp Rheumatol; 1989; 7(3):243-6. PubMed ID: 2758704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pirazolac on arachidonic acid metabolism in the human synovial system.
    Kurowski M; Dunky A; Geddawi M
    Curr Med Res Opin; 1987; 10(7):494-501. PubMed ID: 3040340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.